. 2020 Jun 4;12(6):1469. doi: 10.3390/cancers12061469

Table 4.

Univariate and multivariate analyses of overall prognostic factors in patients with ovarian cancer.

Factors	Patients	Univariate Analysis			Multivariate Analysis
		Hazard Ratio	95% CI	p-Value	Hazard Ratio	95% CI	p-Value
Age
<65	35	1.17	0.28–4.92	0.82	NA	NA	NA
≥65	37	1.17	0.28–4.92	0.82	NA	NA	NA
Grade
G1	15	9.33	1.145–76.17	0.33	NA	NA	NA
G2, G3	57	9.33	1.145–76.17	0.33	NA	NA	NA
FIGO stage
I, II	44	5.96	1.19–29.77	0.02	0.12	0.07–2.04	0.14
III, IV	28	5.96	1.19–29.77	0.02	0.12	0.07–2.04	0.14
Histology
Serous	35	0.51	0.12–2.16	0.365	NA	NA	NA
Others	37	0.51	0.12–2.16	0.365	NA	NA	NA
Residual tumor
<1 cm	54	33.72	4.07–279.15	0.001	124.53	5.19–298.53	0.003
≥1 cm	18	33.72	4.07–279.15	0.001	124.53	5.19–298.53	0.003
RLT
Long	40	12.44	1.15–102.23	0.01	16.29	1.02–259.67	0.04
Short	32	12.44	1.15–102.23	0.01	16.29	1.02–259.67	0.04

CI, confidence interval; FIGO, International Freedom of Gynecology and Obstetrics; RLT, relative lymphocyte telomere length.